Daiichi Sankyo Co., Ltd. (DSKYF)
17.72
-0.36
(-2.01%)
USD |
OTCM |
Nov 16, 16:00
Daiichi Sankyo Enterprise Value : 31.27B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 31.27B |
| November 13, 2026 | 31.93B |
| November 12, 2026 | 32.05B |
| November 11, 2026 | 31.13B |
| November 10, 2026 | 31.26B |
| November 09, 2026 | 31.26B |
| November 06, 2026 | 31.43B |
| November 05, 2026 | 32.78B |
| November 04, 2026 | 32.34B |
| November 03, 2026 | 32.34B |
| November 02, 2026 | 32.23B |
| October 30, 2026 | 30.44B |
| October 29, 2026 | 29.91B |
| October 28, 2026 | 28.87B |
| October 27, 2026 | 29.24B |
| October 26, 2026 | 31.79B |
| October 23, 2026 | 29.15B |
| October 22, 2026 | 30.34B |
| October 21, 2026 | 33.32B |
| October 20, 2026 | 33.32B |
| October 19, 2026 | 29.41B |
| October 16, 2026 | 29.41B |
| October 15, 2026 | 30.11B |
| October 14, 2026 | 28.44B |
| October 13, 2026 | 28.22B |
| Date | Value |
|---|---|
| October 12, 2026 | 27.91B |
| October 09, 2026 | 28.06B |
| October 08, 2026 | 28.42B |
| October 07, 2026 | 31.23B |
| October 06, 2026 | 31.23B |
| October 05, 2026 | 31.12B |
| October 02, 2026 | 31.06B |
| October 01, 2026 | 31.06B |
| September 30, 2026 | 31.35B |
| September 29, 2026 | 32.48B |
| September 28, 2026 | 32.48B |
| September 25, 2026 | 33.92B |
| September 24, 2026 | 33.92B |
| September 23, 2026 | 33.92B |
| September 22, 2026 | 33.92B |
| September 21, 2026 | 33.92B |
| September 18, 2026 | 33.10B |
| September 17, 2026 | 32.92B |
| September 16, 2026 | 32.92B |
| September 15, 2026 | 31.19B |
| September 14, 2026 | 32.47B |
| September 11, 2026 | 31.28B |
| September 10, 2026 | 31.28B |
| September 09, 2026 | 31.12B |
| September 08, 2026 | 29.46B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 95.44B |
| Eisai Co., Ltd. | 9.066B |
| Chugai Pharmaceutical Co., Ltd. | 70.06B |
| Santen Pharmaceutical Co., Ltd. | 3.800B |
| Ono Pharmaceutical Co., Ltd. | 6.348B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 530.10M |
| Revenue (Quarterly) | 3.720B |
| Total Expenses (Quarterly) | 3.200B |
| EPS Diluted (Quarterly) | 0.2857 |
| Gross Profit Margin (Quarterly) | 79.49% |
| Profit Margin (Quarterly) | 14.25% |
| Earnings Yield | 5.88% |
| Operating Earnings Yield | 5.66% |
| Normalized Earnings Yield | 5.878 |